CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 198 enrolled
Drug / intervention
EN3835 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04496167
NCT04496167Phase 2Completed
CompareCT.gov

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of the Safety and Efficacy of EN3835 for the Treatment of Adhesive Capsulitis of the Shoulder

Endo Pharmaceuticals·interventional·Posted Aug 3, 2020·Updated Sep 13, 2023

In Brief

A Phase 2 clinical trial evaluating EN3835 and Placebo for Adhesive Capsulitis and Frozen Shoulder. Completed, enrolled 198 participants across 38 sites.

Detailed Summary

This study will evaluate the safety and efficacy of EN3835 for the treatment of adhesive capsulitis of the shoulder (frozen shoulder).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdhesive Capsulitis, Frozen Shoulder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
202120222023202420252026
First PostedAug 3, 2020
Enrollment StartJul 29, 2020
Primary CompletionApr 14, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.9 years ago

Interventions

EN3835drug

Collagenase clostridium histolyticum

Placebodrug

Placebo comparator